ABACUS MEDICINE A/S — Credit Rating and Financial Key Figures
CVR number: 28111576
Kalvebod Brygge 35, 1560 København V
info@abacusmedicine.com
tel: 70220212
www.abacusmedicine.com
Income statement (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 558.97 | 671.13 | 675.31 | 832.25 | 981.86 |
| Costs of manufacturing | - 512.96 | - 626.79 | - 615.69 | - 744.97 | - 882.00 |
| External services | -17.62 | -14.20 | -14.15 | -22.76 | -33.33 |
| Gross profit | 28.39 | 30.13 | 45.47 | 64.52 | 66.53 |
| Employee benefit expenses | -15.13 | -15.90 | -22.28 | -29.90 | -34.82 |
| Other operating expenses | -0.48 | ||||
| Total depreciation | -3.87 | -4.80 | -6.17 | -6.75 | -7.16 |
| EBIT | 8.91 | 9.43 | 17.01 | 27.86 | 24.55 |
| Other financial income | 0.13 | 0.48 | 0.86 | 4.05 | 4.68 |
| Other financial expenses | -3.21 | -3.84 | -4.97 | -10.76 | -10.80 |
| Net income from associates (fin.) | -4.30 | -4.09 | -4.36 | 3.67 | 3.56 |
| Pre-tax profit | 1.53 | 1.97 | 8.54 | 24.81 | 21.99 |
| Income taxes | -1.10 | -1.56 | -2.72 | -4.77 | -4.37 |
| Net earnings | 0.43 | 0.41 | 5.82 | 20.04 | 17.62 |
Assets (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 17.05 | 20.79 | 22.55 | 23.23 | 26.49 |
| Intangible assets total | 17.05 | 20.79 | 22.55 | 23.23 | 26.49 |
| Machinery and equipment | 0.67 | 0.51 | 0.37 | 0.18 | 0.08 |
| Other tangible assets | 0.58 | 5.32 | 4.17 | 3.40 | 2.14 |
| Tangible assets total | 1.25 | 5.83 | 4.54 | 3.58 | 2.22 |
| Holdings in group member companies | 20.46 | 17.68 | 15.78 | 21.02 | 25.51 |
| Investments total | 20.46 | 17.68 | 15.78 | 21.02 | 25.51 |
| Non-current other receivables | 0.13 | 0.04 | |||
| Long term receivables total | 0.13 | 0.04 | |||
| Inventories total | 95.39 | 90.56 | 98.74 | 169.64 | 194.05 |
| Current trade debtors | 32.42 | 37.78 | 38.30 | 68.34 | 68.58 |
| Short term receivables total | 32.42 | 37.78 | 38.30 | 68.34 | 68.58 |
| Cash and bank deposits | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash and cash equivalents | 0.00 | 0.00 | 0.00 | 0.00 | |
| Balance sheet total (assets) | 166.71 | 172.68 | 179.90 | 285.82 | 316.85 |
Equity and liabilities (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 |
| Other reserves | -0.04 | 0.57 | 1.32 | 1.17 | -1.52 |
| Retained earnings | 52.12 | 53.14 | 53.34 | 59.13 | 79.27 |
| Profit of the financial year | 0.43 | 0.41 | 5.82 | 20.04 | 17.62 |
| Shareholders equity total | 53.02 | 54.65 | 60.99 | 80.87 | 95.89 |
| Non-current leasing loans | 0.16 | 4.67 | 3.45 | 2.63 | 1.23 |
| Non-current other liabilities | 1.25 | 1.25 | 1.25 | 1.34 | 1.39 |
| Non-current deferred tax liabilities | 3.30 | 4.24 | 4.33 | 1.78 | 1.49 |
| Non-current liabilities total | 4.71 | 10.16 | 9.03 | 5.75 | 4.11 |
| Current leasing loans | 0.43 | 0.84 | 1.24 | 1.32 | 1.42 |
| Current trade creditors | 41.95 | 36.67 | 41.27 | 106.93 | 143.20 |
| Short-term deferred tax liabilities | 0.74 | 0.55 | 2.46 | 6.89 | 3.87 |
| Other non-interest bearing current liabilities | 59.85 | 65.69 | 60.67 | 78.67 | 62.03 |
| Current provisions | 6.01 | 4.13 | 4.26 | 5.39 | 6.33 |
| Current liabilities total | 108.98 | 107.88 | 109.89 | 199.20 | 216.85 |
| Balance sheet total (liabilities) | 166.71 | 172.68 | 179.90 | 285.82 | 316.85 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.